from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1249c/-

LFCtreatmentdescriptionclass of inhibitor

1.319

Amikacinug/mL Amikacintranslation

0.717

Cap5-10ug/mL Capreomycintranslation

0.269

Rox10-50 ug/mL Roxithromycintranslation

0.346

SM2-5 ug/mL Streptomycintranslation

2.312

Tet5-10 ug/mL Tetracyclinetranslation

1.329

Rif0.2-5ug/mL Rifampicintranscription

-0.563

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.289

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.118

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.823

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.236

Clofazimine10-13 ug/mL Clofaziminerespiration

0.009

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.435

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.362

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.687

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.125

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.320

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.572

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.194

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.244

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.785

KCN5-20 ug/mL Potassium cyaniderespiration

0.021

NaN30.2-2 mM Sodium aziderespiration

-0.708

Nigericin50 uM Nigericinrespiration

0.544

TRC10-150 ug/mL Triclosanrespiration

0.847

TRZ10-25 ug/mL Thioridazinerespiration

-0.479

Valinomycin0.5-10 uM Valinomycinrespiration

0.160

ZnSO42 mM ZnSO4respiration

0.254

menadione6-10 ug/mL Menadionerespiration

0.204

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.242

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.082

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.854

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.415

NRP_1Non-replicating persistence stage 1dosRassociated

-0.850

Amp0.2mg/mL AmpicillincellWall

-0.082

Cephalexin20-100 ug/mL CephalexincellWall

-0.173

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.345

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.200

EMB10-20 ug/mL EthambutolcellWall

0.326

Eta12-40 ug/mL EthionamidecellWall

0.747

INH0.2-0.4 ug/mL IsoniazidcellWall

0.005

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.496

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.256

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.390

BZA0.12 mg/mL BenzamidearomaticAmides

-0.057

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.221

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.745

H2O24 mM hydrogen peroxideDNAdamaging

0.130

Levo10 ug/mL LevofloxacinDNAdamaging

-0.720

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.656

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.351

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.502

UVUV-irradiationDNAdamaging

0.208

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.176

Antimycin12.5-50 ug/mL Antimycin A?

-0.947

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.546

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.764

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.109

PA8240.2-2 ug/mL PA-824?

-0.725

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.049

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.468

Verapamil50 uM Verapamil?

-0.213

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.832

methoxatin10-20 ug/mL Methoxatin?